Biomed Israel 2023
Pioneering the field of precision medicine, NeuroKaire (formerly Genetika+) employs state-of-the-art technology to transform extensive datasets into actionable insights.
Our CEO, Talia Cohen Solal presented at Biomed Israel and participated in an amazing panel representing the future of treatment in Neurological Disorders.
She was joined by the inspirational keynotes by Barry Greene of Sage Therapeutics and Clément Gautier of Ipsen, and the presentations from industry leaders including Biogen President & CEO, Christopher Viehbacher, Prilenia's Head of Research, Michal G., BrainQ Technologies Founder & CEO, Yotam Drechsler, NeuroGenesis Co-Founder & CEO, Tal Gilat, Theranica Bio-Electronics Ltd. CEO, Alon Ironi and Firefly Neuroscience CTO, Gil Issachar.
Contact Us
78 John Miller Way,
Kearny, NJ 07032, USA
Yigal Alon Street 126
Tel Aviv-Yafo, Israel